Hematology Transfusion and Cell Therapy

Hematology Transfusion and Cell Therapy(英文缩写 HEMATOL TRANSF CELL),ISSN 2531-1379,eISSN 2531-1379 是一本学术期刊。本页汇总该期刊的最新影响因子、分区信息以及最新收录于 PubMed 的文献,帮助您快速了解期刊全貌。

指标来源：jcr_cas_ifqb

历年影响因子趋势

Hematology Transfusion and Cell Therapy 最新收录文献

1. IRAK1 expression in bone marrow cells does not impact patient outcomes in myelodysplastic syndromes.
   Paula de Melo Campos, João Agostinho Machado-Neto, Irene Lorand-Metze, Fernando Ferreira Costa, Sara Teresinha Olalla Saad, Fabiola Traina
   Hematology, transfusion and cell therapy IF: 1.50 Q3 PMID: 29519376
   查看详情 DOI
2. Bleomycin induced hyperpigmentation of skin.
   Kundan Mishra, Aditya Jandial, Gaurav Prakash
   Hematology, transfusion and cell therapy IF: 1.50 Q3 PMID: 29519375
   查看详情 DOI
3. {"_":"Compound heterozygote of Hb D [HBB: c.67G>C, β 22(B4) Glu>Gln] with β-thalassemia [cds 41/42 (-CTTT)] from Eastern India.","sup":["Iran","0"]}
   Pradeep Kumar Mohanty, Satyabrata Meher, Snehadhini Dehury, Subhra Bhattacharya, Kishalaya Das, Siris Patel
   Hematology, transfusion and cell therapy IF: 1.50 Q3 PMID: 29519374
   查看详情 DOI
4. Novel mutations associated with pyruvate kinase deficiency in Brazil.
   Maria Carolina Costa Melo Svidnicki, Andrey Santos, Jhonathan Angel Araujo Fernandez, Ana Paula Hitomi Yokoyama, Isis Quezado Magalhães, Vitoria Regia Pereira Pinheiro
   Hematology, transfusion and cell therapy IF: 1.50 Q3 PMID: 29519373

   Pyruvate kinase deficiency is a hereditary disease that affects the glycolytic pathway of the red blood cell, causing nonspherocytic hemolytic anemia. The disease is transmitted as an autosomal recess…

   查看详情 DOI
5. Can dentists detect multiple myeloma through oral manifestations?
   Thaís Miranda Xavier de Almeida, Édila Figuerêdo Feitosa Cavalcanti, Alessandra da Silva Freitas, Roberto José Pessoa de Magalhães, Angelo Maiolino, Sandra Regina Torres
   Hematology, transfusion and cell therapy IF: 1.50 Q3 PMID: 29519372

   To review published data on oral manifestations of multiple myeloma. An electronic database search was performed of articles published from 1971 to November 2016 in order to identify studies that repo…

   查看详情 DOI
6. Mortality in children, adolescents and adults with sickle cell anemia in Rio de Janeiro, Brazil.
   Clarisse Lopes de Castro Lobo, Emilia Matos do Nascimento, Leonardo José Carvalho de Jesus, Thiago Gotelip de Freitas, Jocemir Ronaldo Lugon, Samir K Ballas
   Hematology, transfusion and cell therapy IF: 1.50 Q3 PMID: 29519371

   To determine the mortality rate of children, adolescents and adults with sickle cell anemia in Rio de Janeiro, Brazil. The number of deaths, the mortality rate and the causes of deaths in patients wit…

   查看详情 DOI
7. Multiple myeloma and central nervous system involvement: experience of a Brazilian center.
   Ana Luiza Miranda Silva Dias, Fabiana Higashi, Ana Lúcia M Peres, Pricilla Cury, Edvan de Queiroz Crusoé, Vânia Tietsche de Moraes Hungria
   Hematology, transfusion and cell therapy IF: 1.50 Q3 PMID: 29519370

   The estimated involvement of the central nervous system in patients with multiple myeloma is rare at about 1%. The infiltration can be identified at the time multiple myeloma is diagnosed or during it…

   查看详情 DOI
8. The interpretation of rare or novel variants: damaging vs. disease-causing.
   Fernanda Gutierrez-Rodrigues, Rodrigo T Calado
   Hematology, transfusion and cell therapy IF: 1.50 Q3 PMID: 29519369
   查看详情 DOI
9. Transfusion management for patients taking an anti-CD38 monoclonal antibody.
   Carolina Bonet Bub, Isabel Nagle Dos Reis, Maria Giselda Aravechia, Leandro Dinalli Santos, Eduardo Peres Bastos, José Mauro Kutner
   Hematology, transfusion and cell therapy IF: 1.50 Q3 PMID: 29519368

   Pre-transfusion tests, essential for the release of blood components, may be affected by drugs. Monoclonal antibodies represent a class of medications increasingly used in the clinical practice, with …

   查看详情 DOI
10. Validation of the Brazilian version of the VERITAS-Pro scale to assess adherence to prophylactic regimens in hemophilia.
    Adriana Aparecida Ferreira, Isabel Cristina Gonçalves Leite, Natalie August Duncan
    Hematology, transfusion and cell therapy IF: 1.50 Q3 PMID: 29519367

    Prophylaxis is the treatment of choice for patients with severe hemophilia. Low adherence may limit the effectiveness of the prophylactic regimen, thereby compromising outcomes. The objective of this …

    查看详情 DOI